In his April 21 first-quarter preview, Rohit Kulkarni, Managing Director and Senior Research Analyst at Roth Capital Partners maintained his “Buy” rating on Meta Platforms (Meta Platforms Inc. Stock Quote, Chart, News, Analysts, Financials NASDAQ:META) with a 12-month price target of $580, down from a previous target of $730. The stock closed at $484.66 on […]

Source

Commitment anticipated to support more than 20,000 STEM seats across the province per year.

The post Government of Ontario investing $750 million in STEM programs to bolster talent pool in face of tariff threats first appeared on BetaKit.

Commercialization is a national imperative at Remarkable 2025.

The post Can Canada become the best in the world at using AI? first appeared on BetaKit.

Rivian looks to integrate AI as it branches into more affordable models in the next few years.

The post Electric vehicle maker Rivian elects Cohere CEO Aidan Gomez to board of directors first appeared on BetaKit.

Raymond James bullish rating for Bausch Health Companies (Bausch Health Companies NAME Stock Quote, Chart, News, Analysts, Financials NYSE:BHC) remains unchanged after a U.S. District Court ruling on April 17, which granted summary judgment in favour of Bausch Health and Teva, denying Norwich Pharmaceuticals’ attempt to launch a generic version of Xifaxan before January 2028. […]

Source

A bipartisan group in the U.S. House of Representatives has reintroduced the STATES 2.0 Act, a cannabis reform bill that would exempt state-legal marijuana markets from federal interference and eliminate the 280E tax provision that prevents cannabis companies from claiming standard business deductions. The legislation, formally titled the Strengthening the Tenth Amendment Through Entrusting States […]

Source

Good company, bad environment. That’s the takeaway from RBC Dominion Securities analyst Paul Treiber’s latest report on Celestica (Celestica Stock Quote, Chart, News, Analysts, Financials NYSE:CLS). As reported by the Globe and Mail, Treiber April 22 maintained his “Outperform” rating on CLS while chopping his price target on the stock from (US) $160.00 to $120.00. […]

Source

Co-CEO says the rise of AI agents has created business security concerns.

The post 1Password expands Extended Access Management platform with agentic AI security first appeared on BetaKit.

Macroeconomic uncertainty inspired invoice factoring platform to raise $34.6 million CAD.

The post FundThrough acquires American company Ampla alongside fresh Series B funding first appeared on BetaKit.

Montréal-based companies lead the pack of B2B SaaS startups selected for 10-week program.

The post Latest Google for Startups Accelerator cohort makes AI de facto entry requirement first appeared on BetaKit.

Teachers-backed unicorn aims to help disrupt Canada’s health insurance market.

The post France’s Alan comes to Canada with digital group health insurance for tech startups first appeared on BetaKit.

Rohit Kulkarni, Managing Director and Senior Research Analyst at Roth is maintaining his “Buy” rating for Alphabet Inc. (Alphabet Inc. Stock Quote, Chart, News, Analysts, Financials NYSE:GOOGL), with a 12-month price target of $180.00. At the time of his April 17 report, the stock was trading at $151.16, suggesting a return potential of 19%. Kulkarni […]

Source

Amr Ezzat, an analyst with Ventum Capital Markets, says Sylogist’s (Sylogist Stock Quote, Chart, News, Analysts, Financials TSXV:SYZ) recent US$10.6-million statewide contract win in Texas is a strong endorsement of the company’s Victim Services Suite and its overall strategy. This marks Sylogist’s third VSS deal in the U.S. this year and, according to Ezzat, “represents […]

Source

In a research update to clients April 9, Beacon analyst Gabriel Leung kept his “Buy” rating on VerticalScope Holdings (Stock Quote, Chart, News, Analysts, Financials TSXV:FORA) but lowered the 12-month price target from $19.50 to $12.00. VerticalScope issued a business update and revised its 2025 financial outlook on April 8, warning of ongoing challenges. Since […]

Source

Edmonton-based healthtech startup aims to reduce disease through preventative health testing.

The post Long-life startup NiaHealth exits stealth with $2.5 million in pre-seed funding first appeared on BetaKit.

Cohere says first movers on AI agents will gain “competitive advantage.”

The post At World Summit AI, cautious tone of researchers drowned out by cutthroat adoption race first appeared on BetaKit.

Raymond James analyst Michael W. Freeman thinks NervGen Pharma (NervGen Pharma Corp Stock Quote, Chart, News, Analysts, Financials TSXV:NGEN) is undervalued. In a research update to clients April 8th, the analyst maintained his “Outperform” rating and target price of $4.50 per share on the stock. At a recent event, NervGen highlighted the urgent need for […]

Source

Desjardins Securities analyst Jerome Dubreuil says forget the scalpel, what’s needed is a machete. That’s the analysts opinion when it comes to the anticipated dividend cut at BCE (BCE Stock Quote, Chart, News, Analysts, Financials TSX:BCE). Dubreuil, ahead of the company’s Q1, 2025 results, due May 8, says a 50% dividend cut is required for […]

Source

Plus: Yoshua Bengio warns of agentic AI's “catastrophic risks.”

The post Canadian VCs have performance anxiety first appeared on BetaKit.

From tweet to volunteer-run non-profit: inaugural Toronto Tech Week will feature over 100 events.

The post How Toronto Tech Week plans to host 10,000 people this June first appeared on BetaKit.